About TYME
Our Science
TYME Trials
Data Publications
- Scientific Presentations
- Publications
Newsroom
Investors

Events

About TYME
Our Science
TYME Trials
Data Publications
- Scientific Presentations
- Publications
Newsroom
Investors

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Tyme Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Tyme Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Release
Events & Presentations
SEC Filings
EOD Stock Quote
Reports

Unsubscribe



Enter the code shown above.

Email Alert Sign Up Confirmation

Contact Us

For IR related inquiries:
investorrelations@tymeinc.com

1 Pluckemin Way, Suite 103
Bedminster, NJ 07921

212-461-2315

Now Enrolling!

TYME-88-Panc Trial currently enrolling patients with advanced pancreatic cancer!

To learn more download the flyer here and submit your information.

A study representative will be in touch shortly.